In one paragraphArticle in Biomedicines, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
11 authors.
Ana Sofia MartinsMolecular Oncology and Viral Pathology Group, IPO Porto Research Center (CI-IPO Porto), Portuguese Oncology Institute of Porto (IPO Porto), 4200-072 Porto, Portugal.
Mariana FerreiraMolecular Oncology and Viral Pathology Group, IPO Porto Research Center (CI-IPO Porto), Portuguese Oncology Institute of Porto (IPO Porto), 4200-072 Porto, Portugal.
Cláudia VieiraDepartment of Oncology, Portuguese Oncology Institute of Porto (IPO Porto), 4200-072 Porto, Portugal.
Otília RomanoPhysical and Rehabilitation Medicine Clinic, Portuguese Oncology Institute of Porto (IPO Porto), 4200-072 Porto, Portugal.
Rosário RodriguesDepartment of Medicine, Portuguese Oncology Institute of Porto (IPO Porto), 4200-072 Porto, Portugal.
Catarina CastroMolecular Oncology and Viral Pathology Group, IPO Porto Research Center (CI-IPO Porto), Portuguese Oncology Institute of Porto (IPO Porto), 4200-072 Porto, Portugal.ORCID 0000-0002-8970-6493 Ana Paula MoreiraNursing Management Department, Portuguese Oncology Institute of Porto (IPO Porto), 4200-072 Porto, Portugal.
María Teresa Carrillo-de-la-PeñaBrain and Pain (BaP) Lab, Departamento de Psicoloxía Clínica y Psicobioloxía, Facultade de Psicoloxia, Universidade de Santiago de Compostela, Campus Vida, 15782 Santiago de Compostela, A Coruña, Spain.ORCID 0000-0001-6940-2460 Ana Luísa TeixeiraMolecular Oncology and Viral Pathology Group, IPO Porto Research Center (CI-IPO Porto), Portuguese Oncology Institute of Porto (IPO Porto), 4200-072 Porto, Portugal.ORCID 0000-0002-7489-2211 Rui MedeirosMolecular Oncology and Viral Pathology Group, IPO Porto Research Center (CI-IPO Porto), Portuguese Oncology Institute of Porto (IPO Porto), 4200-072 Porto, Portugal.ORCID 0000-0003-3010-8373 Funding
European Union 101057367
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
cancer painlongitudinal studiespain measurementquantitative sensory testingsensory thresholdssomatosensory disorders
Identifiers
PMID42652220
PMCPMC13509572
What Socratic holds
Textmetadata
Read underepoch 390